The University of Kansas Medical Center, commonly referred to as KU Med or KUMC, is a medical campus for the University of Kansas. KU Med houses the university's schools of medicine, nursing, and health professions, with the primary health science campus in Kansas City, Kansas.

During the past decade, University of Kansas Cancer Center - North conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 64 clinical trials were completed, i.e. on average, 46% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 46 clinical trials were completed. i.e. 71.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Cancer Center - North" #1 sponsor was "National Cancer Institute (NCI)" with 78 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "NRG Oncology" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored and "Radiation Therapy Oncology Group" with 16 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Cancer Center - North" #1 collaborator was "National Cancer Institute (NCI)" with 94 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Cancer Center - North" are "Breast Cancer" (10 trials), "Prostate Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "University of Kansas Cancer Center - North" in a lesser frequency.

Most popular intervention types in "University of Kansas Cancer Center - North" are "Drug" (149 trials), "Other" (98 trials), "Biological" (66 trials), "Radiation" (63 trials) and "Procedure" (53 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (41 trials), "Biospecimen Collection" (30 trials), "Computed Tomography" (28 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Cancer Center - North" are 147 trials for "All" genders, 22 trials for "Female" genders and 22 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kansas Cancer Center - North". undefined are not yet recruiting, 58 are recruiting, 95 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in University of Kansas Cancer Center - North, 5 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Cancer Center - North, 19 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".